Did David Price sell Teva Pharmaceutical Industries stock?

Common questions

Did David Price sell Teva Pharmaceutical Industries stock?

Yes. David Price disclosed 1 sale of Teva Pharmaceutical Industries (TEVA) stock on Jun 19, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were David Price's Teva Pharmaceutical Industries trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did David Price make these Teva Pharmaceutical Industries trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does David Price still own Teva Pharmaceutical Industries stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did David Price report these trades?

The latest filing is dated Jul 11, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.